These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9480082)

  • 1. [Familial investigations of carriers of Rh 33].
    Endres W; Lichy S; Stangel W
    Beitr Infusionsther Transfusionsmed; 1994; 32():187-9. PubMed ID: 9480082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
    Williams M
    Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of RhD agglutination for the detection of weak D red cells by anti-D flow cytometry.
    Grey DE; Davies JI; Connolly M; Fong EA; Erber WN
    Clin Lab Haematol; 2005 Apr; 27(2):127-33. PubMed ID: 15784128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOME CLINICALLY IMPORTANT ERYTHROCYTE BLOOD GROUP ANTIGENS IN DONORS.
    Tsintsadze I; Gorgoshadze T; Donskov S; Akhvlediani L; Nagervadze M
    Georgian Med News; 2016 Sep; (258):54-59. PubMed ID: 27770530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rare Rh haplotypes -D- and --- in a family with A -D-/--- propositus.
    Kendrick L; Dunstan-Adams C; Humphreys J; Plantos M; Moore BP; Lomas C; Daniels GL
    J Immunogenet; 1981 Jun; 8(3):243-7. PubMed ID: 6790629
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing efficacy of anti-D sera by a panel of donor red cells with weak reacting D antigen and with partial D antigens.
    van Rhenen DJ; Thijssen PM; Overbeeke MA
    Vox Sang; 1989; 56(4):274-7. PubMed ID: 2503937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rh-negative donor.
    Contreras M; Knight RC
    Clin Lab Haematol; 1989; 11(4):317-22. PubMed ID: 2514064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of rare rhesus antigens Cx and Ew using monoclonal and polyclonal antibodies in routine laboratory tests].
    Strobel E; Wüllenweber J; Lonicer C
    Infusionsther Transfusionsmed; 1993 Aug; 20(4):157-9. PubMed ID: 8400795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
    Judd WJ; Moulds M; Schlanser G
    Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of weak D with a fully automated solid-phase red cell adherence system.
    Lai M; Mavilia G; d'Onofrio G; Leone G
    Transfusion; 2005 May; 45(5):689-93. PubMed ID: 15847655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expediency of typing rhesus-negative donor blood samples using sera containing anti-Rh''(E) antibodies].
    Mikhaĭlova AA; Kuznetsov KV
    Gematol Transfuziol; 1988 Nov; 33(11):53-5. PubMed ID: 3148486
    [No Abstract]   [Full Text] [Related]  

  • 14. Serological characteristics of partial D antigen category VI in 8 unrelated blood donors.
    van Rhenen DJ; Thijssen PM; Overbeeke MA
    Vox Sang; 1994; 66(2):133-6. PubMed ID: 8184595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt.
    Abdelrazik AM; Elshafie SM; Ezzat Ahmed GM; Abdelaziz HM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2940-4. PubMed ID: 23362929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles.
    Silvy M; Simon S; Gouvitsos J; Di Cristofaro J; Ferrera V; Chiaroni J; Bailly P
    Transfusion; 2011 Feb; 51(2):401-11. PubMed ID: 20723165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel RHCE*02 allele, containing the single-nucleotide change c.460A>G, encodes weakened expression of C and e antigens.
    Hellberg Å; Pesjak E; Karlsson J; Storry JR
    Transfusion; 2016 Sep; 56(9):2391-2. PubMed ID: 27282785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rh33 in two of three German siblings with D+ C+ c+ E- e+ red cells.
    Moores P; Smart E; Sternberger J; Schneider W
    Transfusion; 1991 Oct; 31(8):759-61. PubMed ID: 1926324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a mandatory donor RHD screening in Switzerland.
    Crottet SL; Henny C; Meyer S; Still F; Stolz M; Gottschalk J; Neuenschwander K; Taleghani BM; Gowland P; Frey BM; Fontana S; Hustinx H; Niederhauser C; Gassner C
    Transfus Apher Sci; 2014 Apr; 50(2):169-74. PubMed ID: 24679597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary myelofibrosis: when the clone manifests with Rh phenotype splitting.
    Orlando N; Putzulu R; Nuzzolo ER; Maresca M; Massini G; Capodimonti S; Zini G; Teofili L
    Ann Hematol; 2014 Jun; 93(6):1077-8. PubMed ID: 24149913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.